TherapeuticsMD, Inc. 10-K/A

Exhibit 31.4

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

I, Daniel A. Cartwright, certify that:

(1) I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K/A, for the fiscal year ended December 31, 2019, of TherapeuticsMD, Inc.; and

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: April 28, 2020

/s/ Daniel A. Cartwright

Daniel A. Cartwright

Chief Financial Officer

(Principal Financial and Accounting Officer)